COMPASS Pathways (CMPS) Return on Equity [ROE] (2021 - 2026)
COMPASS Pathways' Return on Equity [ROE] was -191.72% in Q2 2026, down 114.57 percentage points from -77.15% a year earlier and down 61.13 percentage points from the prior quarter.
Powered by 
Analysis
COMPASS Pathways (CMPS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at COMPASS Pathways came in at -565.28%, down 483.73 percentage points from FY2024.
- Return on Equity [ROE] has now declined for four consecutive years, with a five-year change of -492.67 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -81.55% in FY2024 (-23.34 pp), -58.21% in FY2023 (-18.91 pp), -39.30% in FY2022 (-9.47 pp) and -29.83% in FY2021 (+42.78 pp).
- Quarterly Return on Equity [ROE] has moved between -237.14% (Q3 2025) and -20.51% (Q3 2021) over five years.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2024 (a gain of 4.74 percentage points); the worst was Q3 2025 (a drop of 168.30 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | COMPASS Pathways | 1.62 Bn | 1.62 Bn | - | -191.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -191.72% |
| Mar 31, 2026 | -130.58% |
| Sep 30, 2025 | -237.14% |
| Jun 30, 2025 | -77.15% |
| Mar 31, 2025 | -78.71% |
| Dec 31, 2024 | -89.22% |
| Sep 30, 2024 | -68.84% |
| Jun 30, 2024 | -57.35% |
| Mar 31, 2024 | -53.39% |
| Dec 31, 2023 | -49.46% |
| Sep 30, 2023 | -55.69% |
| Jun 30, 2023 | -62.09% |
| Mar 31, 2023 | -55.14% |
| Dec 31, 2022 | -48.69% |
| Sep 30, 2022 | -41.14% |
| Jun 30, 2022 | -34.58% |
| Mar 31, 2022 | -29.49% |
| Dec 31, 2021 | -24.33% |
| Sep 30, 2021 | -20.51% |
| Jun 30, 2021 | -25.49% |
API Access
COMPASS Pathways Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CMPS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CMPS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CMPS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();